What does CUSIP 15117B103 represent in this 13F holders report?

CUSIP 15117B103 is the security identifier for CLDX - CELLDEX THERAPEUTICS INC NEW - COM used to aggregate holder disclosures.

How many institutions held CLDX - CELLDEX THERAPEUTICS INC NEW - COM in Q2 2013?

3 institutional investors reported CLDX - CELLDEX THERAPEUTICS INC NEW - COM for Q2 2013. Use the holders table for investor-level position and value details.

CELLDEX THERAPEUTICS INC NEW - COM (CLDX)

CUSIP: 15117B103

Q2 2013 13F Holders as of 30 Jun 2013

Type / Class: Equity / COM
Total 13F shares: 85,292
Share change: 0
Total reported value: $1,331,000
Price per share: $15.59
Number of holders: 3

Quarterly Holders Quick Answers

What is CUSIP 15117B103?
CUSIP 15117B103 identifies CLDX - CELLDEX THERAPEUTICS INC NEW - COM in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Related Filing Research

Latest 13F filings for newly reported positions.
Latest Schedule 13D/13G reports for ownership changes outside 13F cadence.
Latest 10-Q/10-K reports for financial context tied to this issuer.
Recent insider transactions for executive and insider activity.
SEC investors directory and top value investors for manager drilldown.
Back to full security ownership history.

Explore More Reporting Periods

Jump to adjacent filing periods for faster comparison and easier crawl discovery.

Newer quarter: Q3 2013
Previous quarter: Q1 2013

Recent filing periods for CUSIP 15117B103:

Q4 2023 Q3 2023 Q3 2020 Q2 2020 Q1 2020 Q4 2019 Q3 2019 Q2 2019

Institutional Holders of CELLDEX THERAPEUTICS INC NEW - COM (CLDX) as of Q2 2013

As of 30 Jun 2013, CELLDEX THERAPEUTICS INC NEW - COM (CLDX) was held by 3 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 85,292 shares. The largest 3 holders included CITADEL ADVISORS LLC, WELLS FARGO & COMPANY/MN, and HUNTINGTON NATIONAL BANK. This page lists 3 institutional shareholders reporting positions in this security for the Q2 2013 filing period.

Investor	Option	Weight %	Change %	Value $	* Price	Shares	Share Change	Activity	Report Period

* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.